BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18349181)

  • 1. The effects of oral ondansetron disintegrating tablets for prevention of at-home emesis in pediatric patients after ear-nose-throat surgery.
    Davis PJ; Fertal KM; Boretsky KR; Fedel GM; Ingram MD; Woelfel SK; Hoffmann PC; Gurnaney H; Young MC
    Anesth Analg; 2008 Apr; 106(4):1117-21, table of contents. PubMed ID: 18349181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron oral disintegrating tablets: acceptability and efficacy in children undergoing adenotonsillectomy.
    Cohen IT; Joffe D; Hummer K; Soluri A
    Anesth Analg; 2005 Jul; 101(1):59-63, table of contents. PubMed ID: 15976206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron with propofol reduces the incidence of emesis in children following tonsillectomy.
    Barst SM; Leiderman JU; Markowitz A; Rosen AM; Abramson AL; Bienkowski RS
    Can J Anaesth; 1999 Apr; 46(4):359-62. PubMed ID: 10232720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens.
    Pan PH; Lee SC; Harris LC
    Anesth Analg; 2008 Aug; 107(2):429-38. PubMed ID: 18633020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
    Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
    Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subhypnotic propofol infusion plus dexamethasone is more effective than dexamethasone alone for the prevention of vomiting in children after tonsillectomy.
    Erdem AF; Yoruk O; Alici HA; Cesur M; Atalay C; Altas E; Kursad H; Yuksek MS
    Paediatr Anaesth; 2008 Sep; 18(9):878-83. PubMed ID: 18768048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ondansetron, metoclopramide, and placebo in the prevention of postoperative emesis in children undergoing ophthalmic surgery.
    Bach-Styles T; Martin-Sheridan D; Hughes C; Kaufman S
    CRNA; 1997 Nov; 8(4):152-6. PubMed ID: 9437950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children.
    Stork CM; Brown KM; Reilly TH; Secreti L; Brown LH
    Acad Emerg Med; 2006 Oct; 13(10):1027-33. PubMed ID: 16902049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study.
    Grover VK; Mathew PJ; Hegde H
    Anaesthesia; 2009 Jun; 64(6):595-600. PubMed ID: 19453311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer.
    Corapçioglu F; Sarper N
    Pediatr Hematol Oncol; 2005 Mar; 22(2):103-14. PubMed ID: 15804995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vs late intraoperative administration of tropisetron for the prevention of nausea and vomiting in children undergoing tonsillectomy and/or adenoidectomy.
    Gross D; Reuss S; Dillier CM; Gerber AC; Weiss M
    Paediatr Anaesth; 2006 Apr; 16(4):444-50. PubMed ID: 16618300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scheduled prophylactic ondansetron administration did not improve its antiemetic efficacy after intracranial tumour resection surgery in children.
    Subramaniam K; Pandia MP; Dash M; Dash HH; Bithal PK; Bhatia A; Subramaniam B
    Eur J Anaesthesiol; 2007 Jul; 24(7):615-9. PubMed ID: 17261211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.
    Krobbuaban B; Pitakpol S; Diregpoke S
    J Med Assoc Thai; 2008 May; 91(5):669-74. PubMed ID: 18672630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-controlled analgesia combined with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal surgery.
    Jellish WS; Owen K; Fluder E; Sawicki K; Sinacore J
    J Clin Anesth; 2008 Dec; 20(8):594-600. PubMed ID: 19100932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
    Pectasides D; Dafni U; Aravantinos G; Timotheadou E; Skarlos DV; Pavlidis N; Gaglia A; Kalofonos HP; Fountzilas G
    Anticancer Res; 2007; 27(6C):4411-7. PubMed ID: 18214053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis.
    Stene FN; Seay RE; Young LA; Bohnsack LE; Bostrom BC
    J Clin Anesth; 1996 Nov; 8(7):540-4. PubMed ID: 8910174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.